CD274 and neoplasm: As a co-inhibitory molecule, PD-1 could lead to the attenuation of TCR-mediated signal after the engagement with its ligand PD-L1 (B7-H1) expressed on the surface of tumor cells or antigen-presenting cells in the tumor microenvironment (Freeman et al., 2000) (Figure 1).